| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease
|
Papaldo, P.
|
|
|
17 |
4 |
p. 630-636
|
article
|
| 2 |
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer
|
Schmittel, A.
|
|
|
17 |
4 |
p. 663-667
|
article
|
| 3 |
Biphasic metaplastic sarcomatoid carcinoma of the breast
|
Hennessy, B.T.
|
|
|
17 |
4 |
p. 605-613
|
article
|
| 4 |
Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors
|
Kendall, A.
|
|
|
17 |
4 |
p. 584-587
|
article
|
| 5 |
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
|
Schadendorf, D.
|
|
|
17 |
4 |
p. 563-570
|
article
|
| 6 |
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
|
Giordano, K.F.
|
|
|
17 |
4 |
p. 652-656
|
article
|
| 7 |
Do oncologists discuss expensive anti-cancer drugs with their patients?
|
Thomson, J.
|
|
|
17 |
4 |
p. 702-708
|
article
|
| 8 |
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer
|
Rodenhuis, S.
|
|
|
17 |
4 |
p. 588-596
|
article
|
| 9 |
High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients
|
Bertuzzi, A.
|
|
|
17 |
4 |
p. 719-720
|
article
|
| 10 |
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis
|
Houterman, S.
|
|
|
17 |
4 |
p. 709-712
|
article
|
| 11 |
Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM
|
De Vita, S.
|
|
|
17 |
4 |
p. 720-721
|
article
|
| 12 |
in this issue
|
|
|
|
17 |
4 |
p. 537
|
article
|
| 13 |
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients
|
Peters, S.
|
|
|
17 |
4 |
p. 578-583
|
article
|
| 14 |
Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study
|
Polesel, J.
|
|
|
17 |
4 |
p. 713-718
|
article
|
| 15 |
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas
|
Leyvraz, S.
|
|
|
17 |
4 |
p. 646-651
|
article
|
| 16 |
Melanoma vaccines – they should work
|
Danson, S.
|
|
|
17 |
4 |
p. 539-541
|
article
|
| 17 |
Metachronous gastric MALT lymphoma and early gastric cancer
|
Raderer, M.
|
|
|
17 |
4 |
p. 724
|
article
|
| 18 |
Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study
|
Graesslin, O.
|
|
|
17 |
4 |
p. 637-645
|
article
|
| 19 |
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanoma
|
Bajetta, E.
|
|
|
17 |
4 |
p. 571-577
|
article
|
| 20 |
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy
|
Marty, M.
|
|
|
17 |
4 |
p. 614-622
|
article
|
| 21 |
Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients
|
Berretta, M.
|
|
|
17 |
4 |
p. 721-722
|
article
|
| 22 |
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study
|
Baweja, M.
|
|
|
17 |
4 |
p. 623-629
|
article
|
| 23 |
Pleural tumors as sole primary manifestation of acute promyelocytic leukemia
|
Mueller, B.U.
|
|
|
17 |
4 |
p. 722-723
|
article
|
| 24 |
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
|
de las Peñas, R.
|
|
|
17 |
4 |
p. 668-675
|
article
|
| 25 |
Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history
|
Kim, J.J.
|
|
|
17 |
4 |
p. 657-662
|
article
|
| 26 |
Quality of systematic reviews used in guidelines for oncology practice
|
Vigna-Taglianti, F.
|
|
|
17 |
4 |
p. 691-701
|
article
|
| 27 |
Reply to the Letter to the Editor on ‘Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention’, by C. Christodoulou, G. Tsakalos, E. Galani & D. V. Skarlos (doi:10.1093/annonc/mdj008)
|
Breed, W.
|
|
|
17 |
4 |
p. 724-725
|
article
|
| 28 |
Reply to the Reply to the Letter to the Editor on ‘Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention’, by W. P. M. Breed (doi:10.1093/annonc/mdj085)
|
Christodoulou, C.
|
|
|
17 |
4 |
p. 725
|
article
|
| 29 |
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1
|
Ryan, B.M.
|
|
|
17 |
4 |
p. 597-604
|
article
|
| 30 |
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
|
De Ruysscher, D.
|
|
|
17 |
4 |
p. 543-552
|
article
|
| 31 |
Systemic chemotherapy in inoperable or metastatic bladder cancer
|
Bamias, A.
|
|
|
17 |
4 |
p. 553-561
|
article
|
| 32 |
Table of Contents
|
|
|
|
17 |
4 |
p. i-ii
|
article
|
| 33 |
The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia
|
Hus, I.
|
|
|
17 |
4 |
p. 683-690
|
article
|
| 34 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
|
Gobbi, P.G.
|
|
|
17 |
4 |
p. 676-682
|
article
|
| 35 |
Treatment of liver metastases of colorectal cancer Ann Oncol 2005; 16 Suppl 2: ii144–ii149
|
van de Velde, C.J.H.
|
|
|
17 |
4 |
p. 727
|
article
|
Journal description